Lorenzo Galluzzi (born 1980) is an Italian and French cell biologist best known for his experimental and conceptual contributions to the fields of

cell death Cell death is the event of a biological cell ceasing to carry out its functions. This may be the result of the natural process of old cells dying and being replaced by new ones, as in programmed cell death, or may result from factors such as di ...

autophagy Autophagy (or autophagocytosis; from the Greek language, Greek , , meaning "self-devouring" and , , meaning "hollow") is the natural, conserved degradation of the cell that removes unnecessary or dysfunctional components through a lysosome-depe ...

, tumor metabolism and tumor immunology.

Biography

Galluzzi (born September 26, 1980) is currently assistant professor of Cell Biology in Radiation Oncology at the Department of Radiation Oncology of the

Weill Cornell Medical College Weill Cornell Medicine (; officially Joan and Sanford I. Weill Medical College of Cornell University), originally Cornell University Medical College, is the medical school of Cornell University, located on the Upper East Side of Manhattan in Ne ...

(New York, USA) and Assistant Professor Adjunct at the Department of Dermatology of the

Yale University Yale University is a Private university, private Ivy League research university in New Haven, Connecticut, United States. Founded in 1701, Yale is the List of Colonial Colleges, third-oldest institution of higher education in the United Stat ...

School of Medicine (New Haven, USA).Weill Cornell Medical College - People
Retrieved July 19, 2017 Prior to joining Weill Cornell Medical College (2017), Galluzzi was a Junior Scientist of the Research Team "Apoptosis, Cancer and Immunity" at the Cordeliers Research Center (Paris, France; 2012–2016) under the direction of Dr.

Guido Kroemer Guido Kroemer (born 11 June 1961) is a cell biologist who has made contributions to the understanding of the role of mitochondria in cell death. He is a member of multiple scientific academies in Europe and is one of the most highly cited author ...

. Galluzzi did his post-doctoral training at the Gustave Roussy Cancer Center (Villejuif, France; 2009–2011), after receiving his PhD from the Paris Sud University (Le Kremlin-Bicetre, France; 2005–2008). Galluzzi is associate director of the European Academy for Tumor Immunology (EATI), and Founding Member of the European Research Institute for Integrated Cellular Pathology (ERI-ICP). Galluzzi is best known for his experimental and conceptual contributions to the fields of

, tumor metabolism and tumor immunology. In particular, he provided profound insights into the links between adaptive stress responses in cancer cells and the activation of a clinically relevant tumor-targeting immune response in the context of chemotherapy and radiation therapy. As of today, Galluzzi has published more than 500 scientific articles in more than 100 different international peer-reviewed journals, collaborating with more than 3,000 co-authors. According to

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of Academic publishing, scholarly literature across an array of publishing formats and disciplines. Released in Beta release, beta in November 2004, th ...

, Galluzzi has a

h-index The ''h''-index is an author-level metric that measures both the productivity and citation impact of the publications, initially used for an individual scientist or scholar. The ''h''-index correlates with success indicators such as winning t ...

of 125, placing him amongst the top-50 Italian scientists working in biomedical sciences. According to a survey published by Lab Times, he is currently the 6th and the youngest of the 30 most-cited European cell biologists (relative to the period 2007–2013). In 2021, Galluzzi was nominated Highly Cited Researcher by

Clarivate Analytics Clarivate Plc is a British-American publicly traded analytics company that operates a collection of subscription-based services, in the areas of bibliometrics and scientometrics; business and market intelligence, and competitive profiling ...

in three different disciplines along with only 22 other scientists worldwide all disciplines confounded. In addition to his research and dissemination activity, Galluzzi currently operates as Editor-in-Chief of three journals: OncoImmunology (which he co-founded with Dr.

and Dr. Laurence Zitvogel in 2011), International Review of Cell and Molecular Biology, and Molecular and Cellular Oncology (which he co-founded with Dr.

in 2013). Galluzzi also serves as Founding Editor for Microbial Cell and Cell Stress, and Associate Editor for Cell Death and Disease and Aging.Aging - Editorial Board
Retrieved July 31, 2019

References

{{DEFAULTSORT:Galluzzi, Lorenzo 1980 births Living people Cell biologists